评估脉搏血氧仪远程监测项目对英格兰急诊科就诊的COVID-19患者死亡率和医疗服务利用的影响:一项回顾性匹配队列研究
这项回顾性匹配队列研究纳入2020年10月1日至2021年5月3日期间英格兰急诊科就诊、COVID-19检测阳性且未在首次就诊当日或次日住院或死亡的患者,比较入组COVID-19 Oximetry @home(CO@h)项目者与未入组者的28天结局。主要分析共纳入15621例,其中639例入组CO@h、14982例为对照。入组者死亡 odds 较未入组者低52%(95%CI 7%至75%),但任何后续急诊就诊和急诊住院的 odds 分别高37%(95%CI 16%至63%)和59%(95%CI 32%至91%),入院者中入组者入住重症监护的 odds 低53%(95%CI 7%至76%),住院时间无显著影响。作者认为脉搏血氧仪远程监测可能是早期发现低氧和升级治疗的临床有效且安全的模式,但可能的选择偏倚限制其外推性。
要点
- 在急诊科评估的COVID-19患者中,入组CO@h者28天内死亡 odds 较未入组者低52%(95%CI 7%至75%)。
- 入组CO@h者任何后续急诊就诊 odds 较未入组者高37%(95%CI 16%至63%),急诊住院 odds 高59%(95%CI 32%至91%)。
- 入院患者中,入组CO@h者入住重症监护的 odds 较未入组者低53%(95%CI 7%至76%)。
- 入组CO@h与未入组者住院时间无显著影响。
- 作者认为脉搏血氧仪远程监测可能是急诊评估后早期发现低氧和升级治疗的临床有效且安全的模式,但可能的选择偏倚限制其外推性。
适用人群与场景
- 2020年10月1日至2021年5月3日期间COVID-19检测阳性、在检测日期前3天至后10天内在英格兰急诊科就诊的患者。
- 排除在时间窗内首次急诊就诊当日或次日住院或死亡的患者。
研究设计与关键结果
- 研究类型为回顾性匹配队列研究,纳入英格兰急诊科入组CO@h路径的患者;主要分析共15621例,其中639例入组CO@h、14982例为对照。
- 入组CO@h者28天内全因死亡 odds 较未入组者低52%(95%CI 7%至75%)。
- 入组CO@h者任何后续急诊就诊 odds 较未入组者高37%(95%CI 16%至63%)。
- 入组CO@h者任何急诊住院 odds 较未入组者高59%(95%CI 32%至91%)。
- 入院患者中,入组CO@h者入住重症监护的 odds 较未入组者低53%(95%CI 7%至76%)。
- 入组CO@h与未入组者住院时间无显著影响。
证据类型、等级与局限
- 证据类型:回顾性匹配队列研究。
- 局限:可能的选择偏倚可能限制其外推至其他人群。
对床旁实践的改变
- 作者认为,对于在急诊科评估的患者,脉搏血氧仪远程监测可能是早期发现低氧和升级治疗的临床有效且安全的模式。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: To identify the impact of enrolment onto a national pulse oximetry remote monitoring programme for COVID-19 (COVID-19 Oximetry @home; CO@h) on health service use and mortality in patients attending Emergency Departments (EDs).
METHODS: We conducted a retrospective matched cohort study of patients enrolled onto the CO@h pathway from EDs in England. We included all patients with a positive COVID-19 test from 1 October 2020 to 3 May 2021 who attended ED from 3 days before to 10 days after the date of the test. All patients who were admitted or died on the same or following day to the first ED attendance within the time window were excluded. In the primary analysis, participants enrolled onto CO@h were matched using demographic and clinical criteria to participants who were not enrolled. Five outcome measures were examined within 28 days of first ED attendance: (1) Death from any cause; (2) Any subsequent ED attendance; (3) Any emergency hospital admission; (4) Critical care admission; and (5) Length of stay.
RESULTS: 15 621 participants were included in the primary analysis, of whom 639 were enrolled onto CO@h and 14 982 were controls. Odds of death were 52% lower in those enrolled (95% CI 7% to 75%) compared with those not enrolled onto CO@h. Odds of any ED attendance or admission were 37% (95% CI 16% to 63%) and 59% (95% CI 32% to 91%) higher, respectively, in those enrolled. Of those admitted, those enrolled had 53% (95% CI 7% to 76%) lower odds of critical care admission. There was no significant impact on length of stay.
CONCLUSIONS: These findings indicate that for patients assessed in ED, pulse oximetry remote monitoring may be a clinically effective and safe model for early detection of hypoxia and escalation. However, possible selection biases might limit the generalisability to other populations.
参考来源
- Beaney T, Clarke J, Alboksmaty A, et al. Evaluating the impact of a pulse oximetry remote monitoring programme on mortality and healthcare utilisation in patients with COVID-19 assessed in emergency departments in England: a retrospective matched cohort study. Emerg Med J. 2023. PMID: 36854617. doi:10.1136/emermed-2022-212377
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。